Northpointe Bancshares, Inc.

NYSE:NPB

Banks - Regional

Financial Services
$14.79 +0.11%

+$0.02 today

Market cap
$511.47M
Beta
0.11
P/E (TTM)
3.1
EPS (TTM)
$5.85
Dividend yield
0.56%
52W Low $12.95High $19.48

Volume 0.33M

Average 0.15M

NPB Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Northpointe Bancshares, Inc.NYSE: NPB

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares growth accelerates

Q1 FY2026 weighted avg shares of 15.09M shares rose 16.2% year over year, ahead of the +4.3% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.2% from the prior quarter. Over 3 fiscal years it compounded at -0.9% a year.

Context

  • Weighted avg shares increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +16.2% holds above the trailing-twelve-month pace of +4.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
15.09M+0.2% QoQ
Last fiscal yearDec 2025
14.54M-2.6% YoY
LTMMar 2026
15.05M+4.3% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+16.2%——
1 year-2.6%——
3-year CAGR-0.9%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
14.54M USD
Year-over-year change
-2.6%
4-year CAGR
-18.5%

Weighted Avg Shares vs competitors

How NPB compares with its peers on the latest reported figures

  • NPB's LTM Mar 2026 weighted avg shares of 15.05M shares is the lowest of the 7 companies compared; the peer median is 103.71M shares.
  • Its year-over-year change of +4.3% is the 4th highest of 7, against a peer median of +6.1%.
  • Over three fiscal years its annual growth of -0.9% compares with a peer median of +14.5%.
NPB Competitors Peer median
Weighted Avg Shares for NPB and competitors
Company Period LTM YoY 3-year CAGR
ERASErasca, Inc.LTM Sep 2026310.86M +9.7%+32.5%
LEGNLegend Biotech CorporationLTM Sep 2026185.87M +1.7%+5.0%
ZLABZai Lab LimitedLTM Jun 2026110.81M +34.8%+125.3%
CCCCC4 Therapeutics, Inc.LTM Mar 202696.61M +38.1%+19.3%
CGEMCullinan Therapeutics, Inc.LTM Mar 202659.11M +2.4%+9.3%
ALXOALX Oncology Holdings Inc.LTM Mar 202653.9M +2.3%+9.7%
NPBNorthpointe Bancshares, Inc.LTM Mar 202615.05M +4.3%-0.9%
Peer median (excluding NPB) 103.71M+6.1%+14.5%

Competitors are the stored peer set for NPB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.17M324.24M362.45M390.46M471.18M
Cost of Revenue1.14M68.9M164.68M202.99M231.56M
Gross Profit1.02M255.34M197.77M187.47M239.62M
Gross Margin47.3%78.7%54.6%48.0%50.9%
Research & Development29.88M0000
Selling, General & Admin22.17M159.88M104.29M77.79M93.62M
Operating Expenses52.05M221.65M153.08M114.59M129.23M
Depreciation & Amortization840.94K4.02M4.02M3.8M3.07M
EBITDA(56.67M)37.71M48.7M76.68M113.47M
EBITDA Margin-2613.5%11.6%13.4%19.6%24.1%
Operating Income(51.03M)33.69M44.69M72.88M110.39M
Operating Margin-2353.1%10.4%12.3%18.7%23.4%
Interest Income525.54K166.12M267.38M317.53M380.2M
Interest Expense066.69M166.16M203.32M229.47M
Other Income / Expenses(6.49M)0000
Income Before Tax(57.52M)33.69M44.69M72.88M110.39M
Pre-Tax Margin-2652.3%10.4%12.3%18.7%23.4%
Income Tax Expense(77.7K)10.46M10.93M17.72M26.98M
Net Income(57.44M)23.24M33.76M55.16M83.41M
Net Margin-2648.7%7.2%9.3%14.1%17.7%
EPS (Basic)(1.74)0.921.613.154.92
EPS (Diluted)(1.74)0.921.613.154.85
Weighted Avg Shares33.03M14.92M14.92M14.92M14.54M
Weighted Avg Shares (Diluted)33.03M14.92M14.92M14.92M14.72M

Northpointe Bancshares, Inc.

NYSE:NPB

Intrinsic Alpha fair value

Locked

Current Price

$14.79

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.